Researchers at the Cross Cancer Institute combine two existing drugs to double the life expectancy of patients with multiple myeloma.

A non-invasive, electrode-based cardiac system gives real-time access to heart data without the use of a catheter. This reduces patient discomfort and lowers the time spent gathering cardiac readings from hours to minutes.